SEC Form 4 · accession 0001140361-16-088306
IRADIMED CORP · IRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Roger E. Susi
Officer — CEO, President, Chairman · Director · 10% Owner
Period of report
Nov 29, 2016
Accepted (ET)
Dec 1, 2016 · 7:24 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001325618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 29, 2016 | P | 5,000 | $11.238 | A | 10,000 | D | |
| Common StockF2 | holding | — | — | — | 1,075,000 | I | By Roger E. Susi Revocable Trust | |
| Common StockF2 | holding | — | — | — | 2,362,500 | I | By Matthew Susi 2008 Dynasty Trust | |
| Common StockF2 | holding | — | — | — | 2,362,500 | I | By Phillip Susi 2008 Dynasty Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This transaction was executed in multiple trades at prices ranging from $11.15 to $11.25. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- F2The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.